Table 3.

Prescribed therapies in the cohort study during the follow-up period

Systemic/general therapies
Analgesic/NSAIDs	131 (29.1)
Acetaminophen	211 (46.9)
Antihistaminic	27 (6)
Prednisone	113 (25.1)
Pneumological
Inhalation steroids/β2 agonists	124 (27.6)
Codeine	128 (28.5)
Cardiovascular
Anti-arrhythmics	159 (35.4)
Anti-hypertensives	109 (24.2)
Low molecular weight heparin (LMWH)	61 (13.6)
Neurological and psychiatric
Pregabalin/gabapentin	119 (26.5)
Benzodiazepines	178 (39.6)
Antidepressants	75 (16.7)
Neuroleptic/mood stabilizers	31 (6.9)